CLINICAL RESEARCH

Nancyclotep × CHRU Nancy

A French nuclear medicine center, partnering with you on your trials from diagnosis to therapy

Through its partnership with Nancyclotep, which provides a dedicated clinical research unit, the nuclear medicine department of CHRU Nancy-Brabois conducts phase 1 to 4 clinical trials, in diagnostic imaging as well as in radioligand therapy (RLT), for industrial and academic sponsors.

The dedicated clinical research unit thus handles the set-up and operational follow-up of each study, on one of the most comprehensive technical platforms in France.

View clinical trials Submit a feasibility request
Nuclear medicine department of CHRU Nancy
  • 30 Ongoing clinical studies
  • 700 Patients treated with RLT each year
  • 4 Phase 1 trials conducted since 2023
  • ISO 9001 Certified clinical research activity

01Support

Your single point of contact

A dedicated team manages your trial from start to finish, without multiplying contacts.

Industrial sponsors

  1. 01Feasibility questionnaires and site selection
  2. 02Negotiation of the single agreement and budget grid with CHRU Nancy
  3. 03Patient enrollment, follow-up and data entry
  4. 04Hosting of monitoring visits, audits and inspections

Academic sponsors and CHRU investigators

Support from the scientific idea through to publication:

  • Protocol design
  • Regulatory set-up
  • Funding search
  • Study conduct
  • Dissemination

02Technical platform

A technical platform dedicated to clinical trials

Studies take place in the nuclear medicine department of CHRU Nancy-Brabois.

  • 4 PET/CT scanners including 3 digital
  • 6 gamma cameras including 3 semiconductor cameras: 1 D-SPECT™ and 2 VERITON-CT™
  • 14 rooms dedicated to RLT 7 of which are lead-shielded, on the 11th floor within the endocrinology department
  • 4 hospital pharmacies (PUI) including one dedicated to therapy
  • 1 pharmacokinetics laboratory

Treatments are administered daily under strict radiation protection conditions for both patients and healthcare staff. This set-up makes CHRU Nancy a reference center for theranostics in France, welcoming patients from across the Grand Est region and the Paris area.

03Early phases

An environment dedicated to early-phase trials

The clinical research unit has a laboratory allowing full on-site management of radioactive biological samples.

Equipment

  • −20 °C and −80 °C freezers, with temperature monitoring
  • Gamma counter for measuring radioactivity in blood and urine samples
  • Refrigerated, programmable centrifuge

Services

1 / 5

  1. 01

    PK/PD and dosimetry studies

  2. 02

    Processing of blood samples for liquid biopsy shipment (cfDNA / CTC)

  3. 03

    Bedside sampling by clinical research technicians trained in handling radioactive samples

  4. 04

    Processing, on-site storage and shipment to partner central laboratories

  5. 05

    Dedicated monitoring room, regulatory archiving

04Team

Our team

The entire team is trained in Good Clinical Practice.

Medical team

  • 11 Nuclear medicine physicians
  • 34 Medical radiology technologists

Clinical research unit

  • 1 Coordinating project manager
  • 1 Regulatory project manager
  • 4 Clinical research technicians (radiology technologists and nurse)
  • 2 Radiopharmacists
  • 2 Medical physicists
ISO 9001 - AFAQ - AFNOR Certification

Quality

An ISO 9001-certified activity

The clinical research activity is part of Nancyclotep's ISO 9001-certified quality system.

Contacts

Are you a sponsor?

Send us your feasibility request by contacting our dedicated points of contact directly:

Contact us View clinical trials